Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Statistical Methods in Medical Research|July 15, 2022
A comparison of two frameworks for multi-state modelling, applied to outcomes after hospital admissions with COVID-19Christopher H Jackson, Brian Dm Tom, Peter D Kirwan, et al.Journal of the Royal Statistical Society. Series C, Applied Statistics|January 27, 2018
Clustered multistate models with observation level random effects, mover-stayer effects and dynamic covariates: modelling transition intensities and sojourn times in a study of psoriatic arthritisSean Yiu, Vernon T Farewell, Brian D M TomStatistics in Medicine|August 9, 2016
Trivariate mover-stayer counting process models for investigating joint damage in psoriatic arthritisSean Yiu, Brian D M Tom, Vernon T FarewellJournal of the Royal Statistical Society. Series C, Applied Statistics|July 15, 2017
Exploring the existence of a stayer population with mover-stayer counting process models: application to joint damage in psoriatic arthritisSean Yiu, Vernon T Farewell, Brian D M TomPharmaceutical Statistics|April 17, 2024
Rejoinder to the letter: "Standard and reference-based conditional mean imputation: Regulators and trial statisticians be aware!"Marcel Wolbers, Alessandro Noci, Paul Delmar, et al.Statistical Methods in Medical Research|November 15, 2023
Estimating drug concentration-response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomesSean Yiu, Qing Wang, Francois Mercier, et al.Pharmaceutical Statistics|May 19, 2022
Standard and reference-based conditional mean imputationMarcel Wolbers, Alessandro Noci, Paul Delmar, et al.Statistics in Medicine|January 27, 2025
A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two-Stage ApproachesDanilo Alvares, Jessica K Barrett, François Mercier, et al.Lupus Science & Medicine|May 31, 2022
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trialStephen McDonald, Sean Yiu, Li Su, et al.Neurology|April 21, 2025
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical TrialsLudwig Kappos, Sean Yiu, Frank Dahlke, et al.Pageof 3